GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PT Bundamedik Tbk (ISX:BMHS) » Definitions » Beneish M-Score

PT Bundamedik Tbk (ISX:BMHS) Beneish M-Score : -2.41 (As of May. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is PT Bundamedik Tbk Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.41 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for PT Bundamedik Tbk's Beneish M-Score or its related term are showing as below:

ISX:BMHS' s Beneish M-Score Range Over the Past 10 Years
Min: -3.2   Med: -2.62   Max: -2.38
Current: -2.41

During the past 6 years, the highest Beneish M-Score of PT Bundamedik Tbk was -2.38. The lowest was -3.20. And the median was -2.62.


PT Bundamedik Tbk Beneish M-Score Historical Data

The historical data trend for PT Bundamedik Tbk's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Bundamedik Tbk Beneish M-Score Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - - - -2.38 -2.61

PT Bundamedik Tbk Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.89 -2.77 -2.62 -2.61 -2.41

Competitive Comparison of PT Bundamedik Tbk's Beneish M-Score

For the Medical Care Facilities subindustry, PT Bundamedik Tbk's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Bundamedik Tbk's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Bundamedik Tbk's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where PT Bundamedik Tbk's Beneish M-Score falls into.



PT Bundamedik Tbk Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of PT Bundamedik Tbk for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1089+0.528 * 1.0133+0.404 * 1.2171+0.892 * 0.9162+0.115 * 1.0472
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1289+4.679 * -0.000947-0.327 * 1.1
=-2.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was Rp159,802 Mil.
Revenue was 413751.175 + 389393.79 + 377056.785 + 336311.781 = Rp1,516,514 Mil.
Gross Profit was 194583.731 + 183635.128 + 177153.474 + 153626.39 = Rp708,999 Mil.
Total Current Assets was Rp896,732 Mil.
Total Assets was Rp3,139,015 Mil.
Property, Plant and Equipment(Net PPE) was Rp1,987,195 Mil.
Depreciation, Depletion and Amortization(DDA) was Rp117,293 Mil.
Selling, General, & Admin. Expense(SGA) was Rp207,498 Mil.
Total Current Liabilities was Rp587,961 Mil.
Long-Term Debt & Capital Lease Obligation was Rp705,533 Mil.
Net Income was 10869.956 + 18791.579 + 1946.435 + -5693.367 = Rp25,915 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = Rp0 Mil.
Cash Flow from Operations was 5962.335 + 26723.1 + 2228.455 + -6025.198 = Rp28,889 Mil.
Total Receivables was Rp157,291 Mil.
Revenue was 385435.127 + 430023.569 + 413755.844 + 426009.61 = Rp1,655,224 Mil.
Gross Profit was 181397.886 + 188367.889 + 197587.932 + 216756.758 = Rp784,110 Mil.
Total Current Assets was Rp879,459 Mil.
Total Assets was Rp2,958,146 Mil.
Property, Plant and Equipment(Net PPE) was Rp1,881,175 Mil.
Depreciation, Depletion and Amortization(DDA) was Rp116,602 Mil.
Selling, General, & Admin. Expense(SGA) was Rp200,617 Mil.
Total Current Liabilities was Rp631,691 Mil.
Long-Term Debt & Capital Lease Obligation was Rp476,492 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(159802.375 / 1516513.531) / (157290.907 / 1655224.15)
=0.105375 / 0.095027
=1.1089

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(784110.465 / 1655224.15) / (708998.723 / 1516513.531)
=0.473719 / 0.467519
=1.0133

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (896731.999 + 1987195.164) / 3139014.921) / (1 - (879458.925 + 1881174.847) / 2958146.163)
=0.081264 / 0.066769
=1.2171

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1516513.531 / 1655224.15
=0.9162

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(116602.488 / (116602.488 + 1881174.847)) / (117293.499 / (117293.499 + 1987195.164))
=0.058366 / 0.055735
=1.0472

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(207498.244 / 1516513.531) / (200617.293 / 1655224.15)
=0.136826 / 0.121202
=1.1289

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((705532.989 + 587960.98) / 3139014.921) / ((476492.139 + 631691.227) / 2958146.163)
=0.41207 / 0.374621
=1.1

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(25914.603 - 0 - 28888.692) / 3139014.921
=-0.000947

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

PT Bundamedik Tbk has a M-score of -2.41 suggests that the company is unlikely to be a manipulator.


PT Bundamedik Tbk Beneish M-Score Related Terms

Thank you for viewing the detailed overview of PT Bundamedik Tbk's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Bundamedik Tbk (ISX:BMHS) Business Description

Traded in Other Exchanges
N/A
Address
Jl. Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.

PT Bundamedik Tbk (ISX:BMHS) Headlines

No Headlines